AlzBiomarker
Multiple System Atrophy vs Alzheimer's Disease: sAPPα (CSF)
Meta-analysis showed that the level of sAPPα in the cerebrospinal fluid of people with multiple system atrophy was about 70 percent that of people with Alzheimer's disease (effect size = 0.707, p <0.0001). For comparison, levels of sAPPα in cerebrospinal fluid are similar in control subjects and people with AD.
Loading data...